Is Savara Inc (SVRA) overvalued? · $1.11B cap
Savara Inc (SVRA) is a biotechnology company listed on NASDAQ.
This page asks whether Savara Inc (SVRA) looks expensive on cached numbers — not a short thesis.
No cached income statement for SVRA, so there is no earnings base to call rich or cheap.
SVRA currently screens at market cap $1.11B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SVRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SVRA stock page for the full model, not this heading.
Not investment advice.